TMPRSS2 and neoplasm: In Head and neck squamous cell carcinoma (HNSCC), an aberrant upregulation of a group of specific microRNAs has been highlighted that could target TMPRSS2 at a post-transcriptional level reducing its levels in the tumor [56].